We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A research team formed have tested a new non-toxic contrast agent for magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) ) that could be superior to the current dye, gadolinium…
Ablynx has entered into a research collaboration and global exclusive licensing agreement with Sanofi initially focused on developing and commercializing Nanobody-based therapeutics,,,